文献速递消化与肝胆胰病理细胞病理与分子病理

肝细胞癌:依据世界卫生组织分类的细针穿刺活检联合细胞块形态学谱系与亚型分析

Hepatocellular carcinoma: Morphological spectrum and subtyping as per the World Health Organization classification on FNA biopsy with cell block samples.
PubMed 文献 · Cancer Cytopathol · 2025-01-01

本研究回顾性分析7年间164例疑似肝细胞癌患者的超声引导下细针穿刺活检样本,对160例进行分级(23例高分化、127例中分化、10例低分化),并对126例有细胞块的病例按WHO分类进行亚型划分,26例(20.6%)识别出特定亚型,包括脂肪型肝炎型8例、富淋巴细胞型8例、纤维板层型4例、富中性粒细胞型3例、巨梁状 Massive 型2例和透明细胞型1例,其余100例为经典型肝细胞癌非特殊类型。研究首次证明在细针穿刺活检联合细胞块样本上进行肝细胞癌WHO亚型划分的可行性,对预后判断具有重要意义。

要点

  • 细针穿刺活检联合细胞块可用于肝细胞癌WHO亚型划分,特定亚型占20.6%。
  • 160例分级中,中分化最常见(127例),高分化23例,低分化10例。
  • 应重视通过细针穿刺活检联合细胞块获取组织学诊断以指导预后判断。

核心结论

  • 研究首次证明在细针穿刺活检联合细胞块样本上按当前WHO分类进行肝细胞癌亚型划分是可行的,且对预后判断有重要意义。

研究设计与样本

  • 回顾性分析7年间164例疑似肝细胞癌患者的肝脏肿块超声引导下细针穿刺活检样本,其中126例有细胞块可用于亚型划分。

主要发现

  • 164例患者年龄范围18-88岁(平均60岁),男性140例(85.4%),女性24例(14.6%)。
  • 160例肝细胞癌分级(排除纤维板层型后)显示高分化23例、中分化127例、低分化10例。
  • 126例亚型划分中,26例(20.6%)为特定亚型:脂肪型肝炎型8例、富淋巴细胞型8例、纤维板层型4例、富中性粒细胞型3例、巨梁状 Massive 型2例、透明细胞型1例;其余100例为经典型肝细胞癌非特殊类型。

临床怎么用

  • 在细针穿刺活检中获取细胞块有助于肝细胞癌的WHO亚型划分,从而辅助预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatocellular carcinoma (HCC) may be diagnosed and further subclassified in surgical specimen as per the recent World Health Organization (WHO) classification into several distinct subtypes with prognostic implications. The aim of this study was to apply this WHO classification on fine-needle aspiration biopsy (FNAB) samples of HCC and describe their features. METHODS: This was a retrospective analysis of all ultrasound-guided FNAB of liver mass lesions in patients with suspected HCC (n = 164) over a 7-year period. Detailed morphological assessment of cytopathological features and grading was done and correlated with each other. HCC was subtyped further in cases with available cell blocks (n = 126). RESULTS: A total of 164 cases of HCC were evaluated on FNAB with age range of 18-88 years (mean, 60 years), and with 140 (85.4%) male and 24 (14.6%) female patients. Grading performed on 160 cases of HCC (after excluding fibrolamellar HCC) revealed 23 well differentiated, 127 moderately differentiated, and 10 poorly differentiated HCCs. Subtyping was feasible in 126 cases, of which 26 cases (20.6%) showed specific subtypes that were steatohepatitic (8), lymphocyte-rich (8), fibrolamellar (4), neutrophil-rich (3), macrotrabecular massive (2), and clear cell HCC (1) with remaining cases (100) being conventional HCC, no special type. CONCLUSION: The study demonstrates the feasibility of subtyping HCC (as per the current WHO classification) for the first time on FNAB with cell blocks that carries implication for prognostication and emphasizes the importance of obtaining tissue diagnosis by FNAB with cell blocks.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Dhiman B, Kundu R, Mitra S, et al. Hepatocellular carcinoma: Morphological spectrum and subtyping as per the World Health Organization classification on FNA biopsy with cell block samples. Cancer Cytopathol. 2025. PMID: 40045688. doi:10.1002/cncy.70009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。